2021 Webcasts
Friday, June 18, 2021
Saturday, June 19, 2021
Friday Presentations
Traditional vs. Regional Definitions of IBD
Dermot P.B. McGovern
Current Treatment Algorithms & Management of Comorbidities
Anita Afzali MD, MPH, FACG, AGAF
Applying Treat to Target in Clinical Practice
Uma Mahadevan, MD
Maria T. Abreu, MD
Relevance of Real-World Data in IBD
Millie D. Long, MD, MPH
Positioning Future and Current Therapy for Treatment of Patients with IBD
Gary R. Lichtenstein, MD
Combining MOAs: Combination of Biologic Therapies and Small Molecules in IBD
Asher Kornbluth, MD
Philip Schoenfeld, MD, MSED, MSc (Epi)
Ikuo Hirano, MD
Evolving Role of Microbial Modifications in C. difficile Infection
Paul Feuerstadt, MD, FACG, AGAF
Gastroparesis and Complex Motility Issues
Linda Nguyen, MD
Saturday Presentations
Pathophysiology of IBS: Predisposing Factors and the Role of the Gut-Brain Interactions
Lin Chang, MD
Redefining the 4-5: Diagnosing IBS With a 4-5 Minute History and a Maximum 4-5 Tests
Darren M. Brenner, MD, FACG, AGAF, RFF
Pharmacotherapy for IBS-C/CIC: The Role of OTCs versus Prescription Therapies
Brooks D. Cash, MD, AGAF, FACG, FASGE
Lucinda A. Harris, MS, MD
William D. Chey, MD, FACG
Psychogastroenterology and the Role of Behavioral Intervention in IBS
Laurie Keefer, PhD, AGAF
Controversies and Updates in IBS Guidelines: ACG and AGA IBS-D
Baha Moshiree, MD, MSc, FAGA, FACG